All of Galzus Research' articles are since April 12th. His Twitter account was created last November. I would expect he is someone we all know and have known here for a long time... So that "10 year" thing... that's to make the casual reader assume he's a long established commentator and investment research person. It may be that he posts on the internet and has for 10 years, but not there.
It's also behind a premium wall, so not that many buyers of this stock likely actually read it. It may have been a cover story, like we often see, when our favorite group of shorts, need a justifiable reason for doing what they do, in coordinated fashion.
It has 5 comments, not a sign of immense engagement. This is after a day with immense volume, and an incredible and sudden crash in the stock price, presumably because of "the article". Traders need a cover to act in consort that is NOT direct communication. Such articles can serve that role. Just speculation, given what we see frequently, and the suspicion that many are voicing, but can't quite put a finger on.
Same thing with our other "favorite" biotech commentator... his articles serve as an opportune "catalyst" to coordinate without coordinating, in my humble opinion.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
AI
